Medicare prescription drug coverage gap: Navigating the "doughnut hole" with patients

JAMA

Volumn 297, Issue 8, 2007, Pages 868-870

  Berkowitz, Scott A ^a   Gerstenblith, Gary ^a   Anderson, Gerard F ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; DRUG COST; DRUG MONITORING; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MEDICARE; NOTE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 33847390294     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.8.868     Document Type: Note

References (14)

1. Kaiser Family Foundation. Prescription drug coverage among Medicare beneficiaries [June 2006]. http://www.kff.org/medicare/upload/7453.pdf. Accessed August 2, 2006.
2. PriceWaterhouseCoopers. Significance of the coverage gap under Medicare Part D [June 8, 2006]. http://healthdecisions.org/Medicare/News/default.aspx? doc_id=71146. Accessed August 21, 2006.
3. Kaiser Family Foundation. Kaiser Daily Health Policy Report [July 27, 2006]. http://www.kaisernetwork.org/Daily_reports/rep_index.cfm?DR_ID=38767. Accessed August 2, 2006.
4. Centers for Medicare & Medicaid Services. Medicare and you. http://www.medicare.gov/publications/pubs/pdf/10050.pdf. Accessed February 5, 2007.
5. Cubanski J, Neuman P. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage [published online November 21, 2006]. Health Aff (Millwood). doi:10:1377/hlthaff.26.1.w1.
6. Tseng C-W, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952-960.
7. Senate Democratic Policy Committee Hearing: an Oversight Hearing on Providing Relief to Seniors Who Have Fallen Into the Prescription Drug Donut Hole, 109th Cong, 2nd Sess (2006) (testimony of Robert M. Hayes). http://democrats.senate.gov/dpc/hearings/hearing35/hayes.pdf. Accessed February 5, 2007.
8. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate measurement of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
9. US Food and Drug Administration. Orange book. http://www.fda.gov/cder/ orange/default.htm. Accessed August 2, 2006.
10. Destination Rx. Part D optimizer. http://www.PartDoptimizer.com. Accessed August 21, 2006.
11. US Food and Drug Administration. Information on importation of drugs [August 11, 2005]. http://www.fda.gov/ora/import/default.htm. Accessed October 17, 2006.
12. Simon S. US easing prescription drug border checks [transcript]. National Public Radio. October 7, 2006.
13. Mitka M. Waiver of Part D penalties? JAMA. 2006;296:1720.
14. US Department of Health and Human Services. Medicare [October 13, 2006]. http://www.medicare.gov/pdp-basic-information.asp#whenmpdc. Accessed October 17, 2006.